Latest Content

Newer Therapies for Acute Lymphoblastic Leukemia May Reduce Side Effects

November 19th 2024, 10:00pm

By Spencer Feldman

Article

New treatments for acute lymphoblastic leukemia may lead to fewer side effects than chemotherapy, as they target cancer cells more precisely, an expert said.

Venclexta Regimen Beneficial for Patients with AML and MDS

November 19th 2024, 8:00pm

By Alex Biese

Article

Researchers have found an overall survival benefit and manageable safety profile with Venclexta for patients with AML and MDS.

My Top 10 List for Living With Cancer

November 19th 2024, 6:00pm

By Kelly Irvin

Article

Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.

Why Clinical Trials Don’t Have to Be Patients’ ‘Last Line of Defense’

November 19th 2024, 4:00pm

By Alex Biese

Article

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients with cancer to enroll.

Columvi Shows High Response Rates and Safety in R/R Mantle Cell Lymphoma

November 19th 2024, 2:00pm

By Spencer Feldman

Article

Treatment with Columvi showed a manageable safety profile in heavily pre-treated patients with relapsed or refractory mantle cell lymphoma.

Trial for Patients With High-Risk MDS Misses Goal, Discontinues Study

November 18th 2024, 10:00pm

By Ashley Chan

Article

A trial evaluating the tamibarotene-Vidaza combination in certain patients with newly diagnosed high-risk MDS will be discontinued.

COVID-19 RNA May Be Linked to Metastatic Cancer Regression

November 18th 2024, 8:00pm

By Ashley Chan

Article

RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more research is necessary.

How Do You Survive Cancer Survivorship?

November 18th 2024, 6:00pm

By Jessica Bolz

Article

As a four-time cancer survivor, I can tell you that survivorship means many things to each survivor.

Proactive Health and Holistic Approaches to Prostate Cancer Care

November 18th 2024, 5:29pm

By Joseph F. Renzulli MD, FACS

Video

Panelists discuss the key takeaways from their experiences in treating advanced prostate cancer, emphasizing valuable lessons learned throughout the treatment journey that can guide future patient care and support.

Closing Reflections and the Importance of Early Detection

November 18th 2024, 5:29pm

By Joseph F. Renzulli MD, FACS

Video

Panelists discuss key advice for patients and caregivers navigating advanced prostate cancer, highlighting essential insights for those newly diagnosed and sharing valuable guidance received from health care professionals and advocates during their journeys.

How Circulating Tumor Cell Count Can Inform Prostate Cancer Treatment

November 18th 2024, 4:00pm

By Alex Biese

Article

An expert explained how circulating tumor cell count can identify possible clinical trial participants.

Blenrep-Based Combo Provides Survival Benefit in Relapsed/Refractory Multiple Myeloma

November 18th 2024, 2:00pm

By Darlene Dobkowski, MA

Article

Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be presented at an upcoming conference.

Nurse Champions of Patient Safety, Dignity and Leadership

November 17th 2024, 7:00pm

By Erin Longstreth-Papsun, M.S.N., RN, OCN

Article

Three nurses—Maria Hicinbothem, Wandaris Ortiz, and Sandi Wetherbee—are being celebrated for their exceptional dedication to patient care, safety and advocacy.

FDA Receives Application for Dato-DXd Treatment in EGFR-Mutated NSCLC

November 16th 2024, 7:00pm

By Ryan Scott

Article

For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated approval of Dato-DXd.

I’ve Decided What My Legacy Is During Colon Cancer

November 16th 2024, 3:00pm

By Lauryn Cooney

Article

When I was diagnosed with colon cancer, I had a hard time deciding what my legacy should be, but once I realized what it was, I had to keep working hard for it.